A novel, cassette-based nitric oxide delivery system with an advanced feedback control algorithm accurately delivers nitric oxide via the anesthesia machine independent of fresh gas flow rate and volatile anesthetic agent
- PMID: 38822941
- PMCID: PMC11427483
- DOI: 10.1007/s10877-024-01143-4
A novel, cassette-based nitric oxide delivery system with an advanced feedback control algorithm accurately delivers nitric oxide via the anesthesia machine independent of fresh gas flow rate and volatile anesthetic agent
Abstract
Nitric oxide (NO), a selective pulmonary vasodilator, can be delivered via conventional ICU and anesthesia machine ventilators. Anesthesia machines are designed for rebreathing of circulating gases, reducing volatile anesthetic agent quantity used. Current cylinder- and ionizing-based NO delivery technologies use breathing circuit flow to determine NO delivery and do not account for recirculated gases; therefore, they cannot accurately dose NO at FGF below patient minute ventilation (MV). A novel, cassette-based NO delivery system (GENOSYL® DS, Vero Biotech Inc.) uses measured NO concentration in the breathing circuit as an input to an advanced feedback control algorithm, providing accurate NO delivery regardless of FGF and recirculation of gases. This study evaluated GENOSYL® DS accuracy with different anesthesia machines, ventilation parameters, FGFs, and volatile anesthetics. GENOSYL® DS was tested with GE Aisys and Dräger Fabius anesthesia machines to determine NO dose accuracy with FGF < patient MV, and with a Getinge Flow-i anesthesia machine to determine NO dose accuracy when delivering various volatile anesthetic agents. Neonatal and adult mechanical ventilation parameters and circuits were used. GENOSYL® DS maintained accurate NO delivery with all three anesthesia machines, at low FGF with recirculation of gases, and with all volatile anesthetic agents at different concentrations. Measured NO2 levels remained acceptable at ≤ 1 ppm with set NO dose ≤ 40 ppm. GENOSYL® DS, with its advanced feedback control algorithm, is the only NO delivery system capable of accurately dosing NO with anesthesia machines with rebreathing ventilation parameters (FGF < MV) regardless of anesthetic agent.
Keywords: Anesthesia machine; Low-flow anesthesia; Nitric oxide.
© 2024. The Author(s).
Conflict of interest statement
Mark D. Twite reports consulting fees from Vero Biotech Inc. Aaron W. Roebuck reports employment with and stock options in Vero Biotech Inc. Stephanie R. Anderson reports previous employment with Vero Biotech Inc. Patents are planned for the GENOSYL® Delivery System by Vero Biotech Inc. A Dräger Fabius GS Premium anesthesia machine was also provided by Dräger. The authors declare that the work described is original research that has not been published previously. All authors have approved the manuscript.
Figures



References
-
- Frostell CG, Blomqvist H, Hedenstierna G, Lundberg J, Zapol WM. Inhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilation. Anesthesiology. 1993;78:427–35. 10.1097/00000542-199303000-00005. - PubMed
-
- Clark RH, Kueser TJ, Walker MW, et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn: clinical inhaled nitric oxide research group. N Engl J Med. 2000;342:469–74. 10.1056/NEJM200002173420704. - PubMed
-
- Ceccarelli P, Bigatello LM, Hess D, Kwo J, Melendez L, Hurford WE. Inhaled nitric oxide delivery by anesthesia machines. Anesth Analg. 2000;90:482–8. 10.1097/00000539-200002000-00045. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources